Matinas BioPharma Investor Presentation Deck
March 2024, 29 slides
  1. Matinas BioPharma
  2. Related Decks
  3. Investor Presentation Decks
corporate presentation | Matinas BioPharma
forward looking statements | Matinas BioPharma
investment thesis delivery unlocks therapeutic value mat pipeline products and opportunities oral administration a of capabilities | Matinas BioPharma
a clinically validated intracellular delivery platform us as tag | Matinas BioPharma
enables cellular targeting and intracellular delivery | Matinas BioPharma
mat oral clinical validation of delivery | Matinas BioPharma
the growing threat of invasive fungal infections | Matinas BioPharma
mat unlocking the full potential of mat is a promising potential therapeutic option potent only available through | Matinas BioPharma
enact phase clinical validation of safety and efficacy | Matinas BioPharma
results of enact published in highly regarded peer reviewed journal major article a gar oral for meningitis a randomized clinical trial | Matinas BioPharma
mat expanded access program targeted treatment of throughout the body | Matinas BioPharma
mat expanded access compassionate use program demonstrated efficacy in treatment of patients with limited treatment options | Matinas BioPharma
compassionate use recovery from kidney toxicity with mat | Matinas BioPharma
high unmet medical need in invasive aspergillosis with limited treatment options | Matinas BioPharma
mat regulatory and development strategy | Matinas BioPharma
agreed phase study design in invasive aspergillosis the trial | Matinas BioPharma
mat value proposition value oral administration lack of safe long term oral step down with a potent fungicidal agent | Matinas BioPharma
beyond infection efficient and safe delivery of small and chemotherapeutics in inflammation and oncology | Matinas BioPharma
unlocking the full potential of the platform | Matinas BioPharma
are avidly taken up by innate immune cells multiple opportunities in inflammation tiple cog us | Matinas BioPharma
effect of oral a in a murine psoriasis model | Matinas BioPharma
effect of oral in a murine acute colitis model oss i | Matinas BioPharma
target on tumor cells multiple opportunities in oncology tiple improved therapeutic index efficacy | Matinas BioPharma
in therapeutic efficacy of oral in a murine melanoma model | Matinas BioPharma
oral markedly reduces toxicity age coma key | Matinas BioPharma
recent key advances highlight applicability of platform capabilities oncology inflammation | Matinas BioPharma
expanding intellectual property portfolio increasing patent portfolio to increase protection and exclusivity strong regulatory designations | Matinas BioPharma
experienced leadership team reliant a a par | Matinas BioPharma
investment thesis financial summary near term milestones setup for strong start to solid value foundation substantial upside oral delivery of small | Matinas BioPharma
See More
Matinas BioPharma
Investor Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Delivery
Tumor
Inflammation
Oncology
Recent decks by Matinas BioPharma
Investor Presentation
February 2024
Investor Presentation
January 2024
Investor Presentation
November 2023
Investor Presentation
August 2023
See all presentations by Matinas BioPharma (7 decks)
Related decks
Codiak
IPO
October 2020
Alkermes
Investor Presentation
October 2023
Nuvectis Pharma
Investor Presentation
December 2023
BioNTech
Results
May 2021
Nuvectis Pharma
Investor Presentation
July 2023
Relay Therapeutics
IPO
July 2020
Nuvalent
Investor Presentation
October 2022
Chimerix
Mergers and Acquisitions
January 2021
Recent decks by Matinas BioPharma
See all presentations (7 decks)
Investor Presentation
February 2024
Investor Presentation
January 2024
Investor Presentation
November 2023
Investor Presentation
August 2023
Codiak
IPO
October 2020
Alkermes
Investor Presentation
October 2023
Nuvectis Pharma
Investor Presentation
December 2023
BioNTech
Results
May 2021
Nuvectis Pharma
Investor Presentation
July 2023
Relay Therapeutics
IPO
July 2020
Nuvalent
Investor Presentation
October 2022
Chimerix
Mergers and Acquisitions
January 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io